Lexeo Therapeutics Inc (LXEO)

SG&A Expense Growth

35.64%

Quarterly · Period ending:

LXEO logo

LXEO SG&A Expense Growth

Latest reported35.64%
LXEO Quarterly SG&A Growth (QoQ) (0.00% → 35.64%)
High-resolution chart · PNG

LXEO sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lexeo Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
35.641%
-3.9965%
16.0087%
-62.7169%
-4.0099%
84.4942%
11.0345%
16.166%
-7.405%
11.6056%
123.4556%
10.5148%
-3.9621%
-25.1444%
43.7194%
-13.9565%
25.6661%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.